These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6422680)

  • 1. [Antigenic complexes of Pseudomonas aeruginosa slime: their isolation and biological properties].
    Aleksandrov AD; Antsiferova NG; Zhmyrina TI; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):14-9. PubMed ID: 6422680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective cross activity of the extracellular mucus of Pseudomonas aeruginosa].
    Stanislavskiĭ ES; Iushkova NA; Landsman NM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):72-7. PubMed ID: 6412492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
    Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective action of a corpuscular polyvalent Pseudomonas aeruginosa vaccine against representative enterobacteria].
    Vetkova LG; Antsiferova NG; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):26-30. PubMed ID: 2409719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell-free Pseudomonas vaccine: its immunochemical characteristics and immunogenicity].
    Bandman OA; Edvabnaia LS; Bulk VF; Zhvanetskaia MI; Mashilova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):44-7. PubMed ID: 3124416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
    Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
    Podgornaia LG; Dziuban NF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pseudomonas aeruginosa preparations for active immunization].
    Nazarchuk LV
    Vrach Delo; 1991 Jul; (7):22-7. PubMed ID: 1771827
    [No Abstract]   [Full Text] [Related]  

  • 11. [An antigenic analysis and the protective properties of the R-form lipopolysaccharides of gram-negative bacteria].
    Stanislavskiĭ ES; Makarenko TA; Kholodkova EV; Lugowski C
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):52-6. PubMed ID: 9783402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
    Iushkova NA; Stanislavskiĭ ES; Landsman NM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigenic composition and the serological diagnosis of Pseudomonas pseudomallei].
    Kovalev GK
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):109-17. PubMed ID: 2412369
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa vaccine on the basis of antigens isolated from the supernatant of culture media K-4].
    Nuriddinova NR; Ivanova LE; Sheremet'ev NN; Garib FIu
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):40-3. PubMed ID: 12449697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunochemical analysis and protective properties of components of Pseudomonas aeruginosa mucus with different molecular weights].
    Zaĭdner IG; Palkina NA; Stanislavskiĭ ES; Landsman NM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):92-7. PubMed ID: 6791415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide antigens of Pseudomonas aeruginosa.
    Knirel YA
    Crit Rev Microbiol; 1990; 17(4):273-304. PubMed ID: 1698385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell-free Pseudomonas vaccine. III. Immunochemical analysis of purified Pseudomonas aeruginosa protein antigens and protective properties of antisera against these antigens].
    Chekan LV; Stanislavskiĭ ES; Polkina NA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):92-6. PubMed ID: 6188300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.
    Hatano K; Boisot S; DesJardins D; Wright DC; Brisker J; Pier GB
    Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell-free Pseudomonas vaccine. II. Isolation and immunological properties of protective antigens of Pseudomonas aeruginosa].
    Stanislavskiĭ ES; Palkina NA; Bulk VF; Zhvanetskaia MI; Chekan LV
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):37-40. PubMed ID: 6797158
    [No Abstract]   [Full Text] [Related]  

  • 20. The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
    Crowe BA; Enzersberger O; Schober-Bendixen S; Mitterer A; Mundt W; Livey I; Pabst H; Kaeser R; Eibl M; Eibl J
    Antibiot Chemother (1971); 1991; 44():143-56. PubMed ID: 1801633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.